Suppr超能文献

牛奶蛋白不耐受中的白细胞迁移抑制

Leucocyte migration inhibition in cow's milk protein intolerance.

作者信息

Khoshoo V, Bhan M K, Arora N K, Sood D, Kumar R, Stintzing G

出版信息

Acta Paediatr Scand. 1986 Mar;75(2):308-12. doi: 10.1111/j.1651-2227.1986.tb10204.x.

Abstract

The leucocyte migration inhibition (LMI) was determined in an assay after in vitro challenge with beta-lactoglobulin. The assay was considered positive when migration inhibition index was greater than 20% (mean +3 SD of healthy infants). Ninety-eight infants with protracted diarrhoea and failure to thrive, 16 healthy, 12 malnourished, and 16 infants suffering from acute gastroenteritis were studied. Of the 98 patients with protracted diarrhoea, 12 fulfilled Goldman's criteria for cow's milk protein intolerance, 63 had lactose malabsorption, and in 15 no associated causative factor was identified. The mean index of migration inhibition in the cow's milk allergic group (58.83 +/- 11.98) was higher than in healthy controls (8.25 +/- 3.91), the difference being statistically significant (p less than 0.05). The test was positive in all patients with cow's milk protein intolerance. The assay was also positive in four other patients suffering from protracted diarrhoea, two of whom had lactose malabsorption. All the infants with acute gastroenteritis and malnutrition had values within the normal range. The migration inhibition index in five patients with cow's milk intolerance had declined to 24.74 +/- 4.87 in assays performed 1-6 weeks after return of clinical tolerance to cow's milk (p less than 0.05) but the test was still within the positive range in three of the five infants. These results suggest that this cell mediated immune assay is a sensitive test for the diagnosis of cow's milk protein intolerance in infants. The specificity needs to be reassessed in the light of more objective criteria for the diagnosis of cow's milk protein intolerance.

摘要

在用β-乳球蛋白进行体外激发后,通过一项检测来测定白细胞迁移抑制(LMI)。当迁移抑制指数大于20%(健康婴儿的均值+3标准差)时,该检测被认为呈阳性。对98例患有迁延性腹泻和发育不良的婴儿、16例健康婴儿、12例营养不良婴儿以及16例患有急性胃肠炎的婴儿进行了研究。在98例迁延性腹泻患者中,12例符合戈德曼牛奶蛋白不耐受标准,63例有乳糖吸收不良,15例未发现相关致病因素。牛奶过敏组的平均迁移抑制指数(58.83±11.98)高于健康对照组(8.25±3.91),差异具有统计学意义(p<0.05)。所有牛奶蛋白不耐受患者该检测均呈阳性。另外4例患有迁延性腹泻的患者检测也呈阳性,其中2例有乳糖吸收不良。所有患有急性胃肠炎和营养不良的婴儿检测值均在正常范围内。5例牛奶不耐受患者在对牛奶产生临床耐受性恢复后1 - 6周进行的检测中,迁移抑制指数降至24.74±4.87(p<0.05),但这5例婴儿中有3例检测仍在阳性范围内。这些结果表明,这种细胞介导免疫检测对婴儿牛奶蛋白不耐受的诊断是一种敏感的检测方法。鉴于牛奶蛋白不耐受诊断的更客观标准,其特异性需要重新评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验